tetano
Editor, Senior Moderator
Sci Rep
. 2024 Aug 8;14(1):18378.
doi: 10.1038/s41598-024-67931-9. Predicting major clinical events among Canadian adults with laboratory-confirmed influenza infection using the influenza severity scale
Henrique Pott[SUP] 1 2 [/SUP], Jason J LeBlanc[SUP] 3 4 [/SUP], May ElSherif[SUP] 3 [/SUP], Todd F Hatchette[SUP] 3 4 [/SUP], Shelly A McNeil[SUP] 3 5 [/SUP], Melissa K Andrew[SUP] 3 6 [/SUP]; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)
Collaborators, Affiliations
We developed and validated the Influenza Severity Scale (ISS), a standardized risk assessment for influenza, to estimate and predict the probability of major clinical events in patients with laboratory-confirmed infection. Data from the Canadian Immunization Research Network's Serious Outcomes Surveillance Network (2011/2012-2018/2019 influenza seasons) enabled the selecting of all laboratory-confirmed influenza patients. A machine learning-based approach then identified variables, generated weighted scores, and evaluated model performance. This study included 12,954 patients with laboratory-confirmed influenza infections. The optimal scale encompassed ten variables: demographic (age and sex), health history (smoking status, chronic pulmonary disease, diabetes mellitus, and influenza vaccination status), clinical presentation (cough, sputum production, and shortness of breath), and function (need for regular support for activities of daily living). As a continuous variable, the scale had an AU-ROC of 0.73 (95% CI, 0.71-0.74). Aggregated scores classified participants into three risk categories: low (ISS < 30; 79.9% sensitivity, 51% specificity), moderate (ISS ≥ 30 but < 50; 54.5% sensitivity, 55.9% specificity), and high (ISS ≥ 50; 51.4% sensitivity, 80.5% specificity). ISS demonstrated a solid ability to identify patients with hospitalized laboratory-confirmed influenza at increased risk for Major Clinical Events, potentially impacting clinical practice and research.
Keywords: Influenza; Major clinical events; Outcomes; Risk adjustment.
. 2024 Aug 8;14(1):18378.
doi: 10.1038/s41598-024-67931-9. Predicting major clinical events among Canadian adults with laboratory-confirmed influenza infection using the influenza severity scale
Henrique Pott[SUP] 1 2 [/SUP], Jason J LeBlanc[SUP] 3 4 [/SUP], May ElSherif[SUP] 3 [/SUP], Todd F Hatchette[SUP] 3 4 [/SUP], Shelly A McNeil[SUP] 3 5 [/SUP], Melissa K Andrew[SUP] 3 6 [/SUP]; Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)
Collaborators, Affiliations
- PMID: 39112632
- PMCID: PMC11306731
- DOI: 10.1038/s41598-024-67931-9
We developed and validated the Influenza Severity Scale (ISS), a standardized risk assessment for influenza, to estimate and predict the probability of major clinical events in patients with laboratory-confirmed infection. Data from the Canadian Immunization Research Network's Serious Outcomes Surveillance Network (2011/2012-2018/2019 influenza seasons) enabled the selecting of all laboratory-confirmed influenza patients. A machine learning-based approach then identified variables, generated weighted scores, and evaluated model performance. This study included 12,954 patients with laboratory-confirmed influenza infections. The optimal scale encompassed ten variables: demographic (age and sex), health history (smoking status, chronic pulmonary disease, diabetes mellitus, and influenza vaccination status), clinical presentation (cough, sputum production, and shortness of breath), and function (need for regular support for activities of daily living). As a continuous variable, the scale had an AU-ROC of 0.73 (95% CI, 0.71-0.74). Aggregated scores classified participants into three risk categories: low (ISS < 30; 79.9% sensitivity, 51% specificity), moderate (ISS ≥ 30 but < 50; 54.5% sensitivity, 55.9% specificity), and high (ISS ≥ 50; 51.4% sensitivity, 80.5% specificity). ISS demonstrated a solid ability to identify patients with hospitalized laboratory-confirmed influenza at increased risk for Major Clinical Events, potentially impacting clinical practice and research.
Keywords: Influenza; Major clinical events; Outcomes; Risk adjustment.